Alkermes
ALKS
#3169
Rank
A$7.07 B
Marketcap
A$42.83
Share price
-2.30%
Change (1 day)
-10.48%
Change (1 year)

Market capitalization of Alkermes (ALKS)

Market cap: A$7.07 Billion

As of December 2025 Alkermes has a market cap of A$7.07 Billion. This makes Alkermes the world's 3169th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alkermes from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025A$7.07 B-8.01%
2024A$7.68 B13.13%
2023A$6.79 B7.7%
2022A$6.30 B21.61%
2021A$5.18 B25.65%
2020A$4.12 B-10.18%
2019A$4.59 B-29.54%
2018A$6.52 B-39.48%
2017A$10.78 B-8%
2016A$11.71 B-28.64%
2015A$16.42 B55.55%
2014A$10.55 B68.08%
2013A$6.28 B166.16%
2012A$2.35 B7.56%
2011A$2.19 B90.37%
2010A$1.15 B16.52%
2009A$0.98 B-31.15%
2008A$1.43 B-19.72%
2007A$1.78 B4.5%
2006A$1.71 B-28.48%
2005A$2.39 B45.57%
2004A$1.64 B1.66%
2003A$1.61 B124.1%
2002A$0.72 B-78.3%
2001A$3.32 B3.52%
2000A$3.21 B68.38%
1999A$1.90 B148.74%
1998A$0.76 B20.49%
1997A$0.63 B17.48%
1996A$0.54 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Alkermes was reported to be:

A$7.07 Billion
by Nasdaq info icon info icon
A$7.07 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Acorda Therapeutics
ACOR
A$1.23 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$160.32 B 2,167.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$766.01 B 10,732.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$220.86 B 3,023.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$418.53 B 5,818.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$51.35 B 626.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
A$2.25 B-68.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$178.55 B 2,425.03%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
A$382.24 B 5,305.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland